Drug Profile
Budesonide inhalation - Orion
Alternative Names: Budesonide Easyhaler; Easyhaler BudesonideLatest Information Update: 19 Dec 2021
Price :
$50
*
At a glance
- Originator Orion
- Developer Menarini; Orion
- Class Anti-inflammatories; Antiallergics; Antiasthmatics; Antivirals; Glucocorticoids; Pregnenediones; Small molecules
- Mechanism of Action Glucocorticoid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Asthma
Most Recent Events
- 04 Feb 2019 Chemical structure information added
- 13 Dec 2018 Pediapharm is now called Medexus Pharmaceuticals
- 19 Nov 2018 No recent reports of development identified for Preregistration in Asthma prevention in Canada (Inhalation)